aMAZE is an FDA-Approved Trial

Find out if you are eligible

To find out if you are eligible to participate in the aMAZE Trial*, please answer the five questions below. For questions or to request more information, send an email request to amazetrial@sentreheart.com.

  • Persistent – continuous Afib lasting more than seven days
    Longstanding persistent – continuous Afib that lasts for one year or longer
  • This field is for validation purposes and should be left unchanged.

*The aMAZE Trial: Left Atrial Appendage Ligation with the LARIAT Suture Delivery System as Adjunctive Therapy to Pulmonary Vein Isolation (PVI) for Persistent or Longstanding Persistent Atrial Fibrillation.

CAUTION Investigational study device. Limited by Federal law to investigational study use.